Fulvestrant is an effective and well-tolerated endocrine therapy for postmenopausal women with advanced breast cancer: results from clinical trials (Q35750088)
Jump to navigation
Jump to search
scientific article published on March 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Fulvestrant is an effective and well-tolerated endocrine therapy for postmenopausal women with advanced breast cancer: results from clinical trials |
scientific article published on March 2004 |
Statements
1 reference
Fulvestrant is an effective and well-tolerated endocrine therapy for postmenopausal women with advanced breast cancer: results from clinical trials (English)
1 reference
I Vergote
1 reference
J F R Robertson
1 reference
1 March 2004
8 references
13 March 2019
3 April 2019
18 June 2019
17 June 2019
13 November 2019
17 November 2019
15 October 2020
8 references
13 March 2019
3 April 2019
18 June 2019
17 June 2019
13 November 2019
17 November 2019
15 October 2020
1 reference
Identifiers
1 reference